Kettering University

2015–2020 · research · R01

Unraveling resistance to PI3K-alpha inhibitors in breast cancer

Jose Baselga · Kettering University · funded by National Institutes of Health

$436.9kPI3K/AKT/mTOR signaling in cancer

2015–2020 · research · R01

Elucidating and targeting the molecular foundations of IDH mutant glioma

Timothy An-Thy Chan · Kettering University · funded by National Institutes of Health

$570.2kGlioma Diagnosis and Treatment

2015–2021 · cooperative agreement · U54

MSKCC Pilot Center for Precision Disease Modeling

Scott W. Lowe · Kettering University · funded by National Institutes of Health

$2M

2015–2020 · research · R01

Taxi Health Access Interventions for Linkages and Lifestyle (HAILL)

Francesca M Gany · Kettering University · funded by National Institutes of Health

$695.1k

2015–2021 · cooperative agreement · U54

MSKCC -Cornell Center for Translation of Cancer Nanomedicines.

Michelle S Bradbury · Kettering University · funded by National Institutes of Health

$1.7M

2015–2021 · research · R01

Regulation of the intestinal stem cell compartment after hematopoietic transplantation

Alan M Hanash · Kettering University · funded by National Institutes of Health

$570.1k

2015–2022 · research · R01

Selection of Allogeneic Hematopoietic Cell Donor Based on KIR and HLA Genotypes

Katharine C Hsu · Kettering University · funded by National Institutes of Health

$480.6k

2015–2020 · research · R01

Small-Molecule Antibiotics Targeting Siderophore Biosynthesis in M. tuberculosis

Luis E Quadri · Kettering University · funded by National Institutes of Health

$666.7k

2015–2020 · research · R01

Unraveling resistance to PI3K-alpha inhibitors in breast cancer

Jose Baselga · Kettering University · funded by National Institutes of Health

$436.9kPI3K/AKT/mTOR signaling in cancer

2015–2020 · career development · K07

Clinician Use of Non-English Language Skills in Cancer Care

Lisa C Diamond · Kettering University · funded by National Institutes of Health

$180kInterpreting and Communication in Healthcare

2015–2020 · cooperative agreement · U01

Comparative Modeling of Colorectal Cancer: Informing Health Policies and Prioritizing Future Research

Karen M Kuntz · Kettering University · funded by National Institutes of Health

$86.3kColorectal Cancer Screening and Detection

2015–2020 · research · R01

The impact of chromosome 17p lesions on leukemogeneis and therapy response

Scott W. Lowe · Kettering University · funded by National Institutes of Health

$402.4k

2015–2020 · cooperative agreement · U54

MSKCC -Cornell Center for Translation of Cancer Nanomedicines.

Michelle S Bradbury · Kettering University · funded by National Institutes of Health

$1.7M

2015–2029 · research · R01

Regulation of the intestinal stem cell compartment after hematopoietic transplantation

Alan M Hanash · Kettering University · funded by National Institutes of Health

$819.2k

2015–2030 · career development · K12

MSK Paul Calabresi Career Development Award for Clinical Oncology

Omar Abdel-Wahab · Kettering University · funded by National Institutes of Health

$804.7k

2015–2025 · research · R01

Characterizing the MSI2 network in leukemia

Michael Kharas · Kettering University · funded by National Institutes of Health

$413.2k

2015–2025 · research · R01

Role of ETS factors in specifying prostate luminal cell identity and androgen receptor dependence

Charles L. Sawyers · Kettering University · funded by National Institutes of Health

$471.6k

2015–2020 · program · P01

Adoptive Therapy of Ovarian Cancer with Autologous Genetically Modified T Cells

Renier Joseph Brentjens · Kettering University · funded by National Institutes of Health

2015–2021 · cooperative agreement · U54

Nanoparticle Synthesis and Characterization

Teresa J Porri · Kettering University · funded by National Institutes of Health

2015–2021 · program · P01

Pathology Core

Deborah Delair · Kettering University · funded by National Institutes of Health

2015–2021 · cooperative agreement · U54

Melanocortin-1 Receptor Targeted Ultrasmall Silica nanoparticles for Alpha- and

Thomas P. Quinn · Kettering University · funded by National Institutes of Health

2015–2021 · program · P01

Enhanced Efficacy of MUC16 directed antibodies through modification of the Fc domain

Jeffrey Victor Ravetch · Kettering University · funded by National Institutes of Health

2015–2021 · cooperative agreement · U54

Highly-Integrated Ultrasmall and Bright Fluorescent Silica Particle Architectures

Ulrich Wiesner · Kettering University · funded by National Institutes of Health

2015–2021 · cooperative agreement · U54

Developmental Program

Jason S. Lewis · Kettering University · funded by National Institutes of Health

2015–2021 · program · P01

MUC16 Antibody Based Strategies for Imaging and Therapy

David R Spriggs · Kettering University · funded by National Institutes of Health

2015–2021 · program · P01

Biostatistics Core

Alexia E Iasonos · Kettering University · funded by National Institutes of Health

2015–2021 · cooperative agreement · U54

Imaging and Radiochemistry Core

Pat B Zanzonico · Kettering University · funded by National Institutes of Health

2015–2021 · program · P01

Personalized Immunotherapy of Patients with Ovarian Cancer

Paul J Sabbatini · Kettering University · funded by National Institutes of Health

2015–2021 · program · P01

Adminstrative Core

David R Spriggs · Kettering University · funded by National Institutes of Health

2015–2021 · cooperative agreement · U54

Real-time Intraoperative Imaging of Cancer Biomarkers and Peripheral Nerves

Michelle S Bradbury · Kettering University · funded by National Institutes of Health

2015–2021 · cooperative agreement · U54

Administrative Core

Michelle S Bradbury · Kettering University · funded by National Institutes of Health

2014–2020 · program · P50

SPORE in Thyroid Cancer

James A Fagin · Kettering University · funded by National Institutes of Health

$2.1MThyroid Cancer Diagnosis and Treatment

2014–2020 · research · R01

Mechanisms and Function of Myonuclear Positioning

Mary K Baylies · Kettering University · funded by National Institutes of Health

$414.2kMuscle Physiology and Disorders

2014–2020 · research · R01

A new hypothesis: role of p53 inhibitory factors in cellular reprogramming

Kitai Kim · Kettering University · funded by National Institutes of Health

$466.2kPluripotent Stem Cells Research

2014–2024 · research · R01

Mechanism and regulation of Hu family RNA binding proteins during neural alternative polyadenylation

Eric C Lai · Kettering University · funded by National Institutes of Health

$591.6kRNA Research and Splicing

2014–2025 · research · R01

Uncovering the role for MSI2 network in hematopoietic stem cells

Michael Kharas · Kettering University · funded by National Institutes of Health

$632.7k

2014–2026 · research · R01

Mechanisms and Function of Myonuclear Positioning

Mary K Baylies · Kettering University · funded by National Institutes of Health

$590kNuclear Structure and Function

2014–2024 · research · R01

HOMOLOGY-DIRECTED DNA REPAIR PROTEINS BRCA2 AND RAD51 PARALOGS IN TUMOR-RELEVANT TISSUES

Maria Jasin · Kettering University · funded by National Institutes of Health

$426.6k

2014–2023 · research · R01

Mechanism and regulation of Hu family RNA binding proteins during neural alternative polyadenylation

Eric C Lai · Kettering University · funded by National Institutes of Health

$591.6kRNA Research and Splicing

2014–2026 · research · R01

Mechanisms and Function of Myonuclear Positioning

Mary K Baylies · Kettering University · funded by National Institutes of Health

$608.2kNuclear Structure and Function